Form 4: McKesson EVP & CFO Britt J. Vitalone Reports Stock Transactions
SEC Form 4
Britt J. Vitalone, EVP & CFO of McKesson Corp, reports acquisition and disposal of common stock and restricted stock units (RSUs) on May 24, 2024, May 25, 2024, May 28, 2024 and May 29, 2024.
Summary
- Britt J. Vitalone, the EVP & CFO of McKesson Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 24, 2024, Vitalone acquired 1,622 shares of common stock through the vesting of Restricted Stock Units (RSUs) and disposed of 639 shares to cover taxes related to the vesting.
- On May 25, 2024, Vitalone acquired 2,381 shares of common stock through the vesting of RSUs and disposed of 937 shares to cover taxes.
- On May 28, 2024, Vitalone sold 894 shares of common stock at a price of $557.4 per share.
- On May 29, 2024, Vitalone sold 2,427 shares of common stock at a price of $550 per share.
- Following these transactions, Vitalone directly owns 14,028.377 shares of common stock and indirectly owns 548.44 shares through the McKesson Corporation 401(k) Retirement Savings Plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document primarily reports transactions related to RSU vesting and tax obligations, along with pre-planned sales under a 10b5-1 plan. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis to gauge executive sentiment.
- Comparing Vitalone's transactions to those of other CFOs in the healthcare distribution industry could provide insights into McKesson's relative valuation and growth prospects.
- Companies like Cardinal Health (CAH) and AmerisourceBergen (ABC) are direct competitors, and their executives' trading activity is closely watched.
Stakeholder Impact
- Shareholders may monitor insider transactions for insights into management's confidence in the company.
- The transactions themselves are unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/21/2023 | Date of Rule 10b5-1(c) trading arrangement. |
| 05/24/2023 | RSUs vested as to 1/3. |
| 05/25/2022 | RSUs vested as to 1/3. |
| 05/24/2024 | Acquisition of 1,622 shares via RSU vesting; disposal of 639 shares for tax purposes. |
| 05/25/2024 | Acquisition of 2,381 shares via RSU vesting; disposal of 937 shares for tax purposes. |
| 05/28/2024 | Sale of 894 shares at $557.4 per share. |
| 05/29/2024 | Sale of 2,427 shares at $550 per share; Form 4 filing date. |
| 05/24/2025 | RSUs will vest as to 1/3. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.